You need to be logged in to view this video

The Potential and Promise of Psychedelics in Medicine

Released on Thursday, October 7, 2021BIOTECH
Millions of people are experiencing the devastating, often long-term effects of mTBI (mild traumatic brain injury) and PTSD (post-traumatic stress disorder), with few, if any, effective treatments available. Lobe Sciences' goal is to change that fact, and during this presentation, Philip Young, CEO and director, will outline a path for the development of therapeutics for which the company intends to seek FDA approval in the United States, and similar approvals internationally.

Philip Young
Lobe Sciences, CEO and Director

Trending Now

Filter By Category
Filter By Keywords